PIRAMAL, PHARMA

PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND

07.08.2025 - 18:05:14

Piramal Pharma Solutions Italy India Scotland Austria

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approximately 70-80%Adrian Gillespie, Chief Executive of Scottish Enterprise, joins senior Piramal management team and site leadership to mark the occasionThe commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant| LinkedInFacebook | X (formerly Twitter)

About Piramal Pharma Limited

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter products. In addition, one of PPL's associate companies, AbbVie Therapeutics India Private Limited (formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.

For more information visit: www.piramal.com/pharma | LinkedInFacebook | X (formerly Twitter)

About Scottish Enterprise? 

Scottish Enterprise (SE) is Scotland's national economic development agency and a non-departmental public body of the Scottish Government. It supports businesses to innovate and scale to transform the Scottish economy by focusing on new market opportunities through targeted investment, innovation and internationalisation. 

Follow us on X (formerly Twitter) and LinkedIn.

Photo - https://mma.prnewswire.com/media/2303655/Piramal_1.jpg
Photo - https://mma.prnewswire.com/media/2303649/Piramal_2.jpg
Photo - https://mma.prnewswire.com/media/2303651/Piramal_3.jpg
Photo - https://mma.prnewswire.com/media/2303654/Piramal_4.jpg
Photo - https://mma.prnewswire.com/media/2303652/Piramal_5.jpg
Logo - https://mma.prnewswire.com/media/1726186/4462420/Piramal_Pharma_Solutions_Logo.jpg

Ceremonial Ribbon Cutting, Piramal Pharma Solutions Grangemouth, Scotland Site Expansion. Left to right: Adrian Gillespie, Chief Executive of Scottish Enterprise; Herve Berdou, COO, Piramal Pharma Solutions; Francois Houbart, Managing Director and Grangemouth Site Head, Piramal Pharma Solutions; Nandini Piramal, Chairperson, Piramal Pharma Limited; Peter DeYoung, CEO, Piramal Pharma Solutions.

 

External view, Piramal Pharma Solutions Grangemouth, Scotland Site Expansion.

 

Piramal Pharma Solutions Logo

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-solutions-commemorates-opening-of-its-adc-manufacturing-expansion-in-grangemouth-scotland-302018247.html

@ prnewswire.co.uk